Topics

Lower-Cost Competitors Hit Amgen's Blockbusters

18:14 EDT 30 Apr 2019 | SCRIP

Q1 revenue was roughly in line with expectations, but product sales were lower than consensus as multiple blockbusters faced generic...

      

Related Stories

 

Original Article: Lower-Cost Competitors Hit Amgen's Blockbusters

NEXT ARTICLE

More From BioPortfolio on "Lower-Cost Competitors Hit Amgen's Blockbusters"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...